Limits to third-party reporting: Evidence from a randomized field  experiment in Norway - ScienceDirect

Limits to third-party reporting: Evidence from a randomized field experiment in Norway - ScienceDirect

4.7
(735)
Escribir comentario
Más
€ 10.50
Añadir al carro
En stock
Descripción

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial - The Lancet

Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial - The Lancet Neurology

Medicina, Free Full-Text

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial - The Lancet Oncology

On the trajectory of discrimination: A meta-analysis and forecasting survey capturing 44 years of field experiments on gender and hiring decisions - ScienceDirect

Frontiers The Impact of Social Support and Pregnancy on Subjective Well-Being: A Systematic Review

Quality Improvement

Evidence of households' demand flexibility in response to variable hourly electricity prices – Results from a comprehensive field experiment in Norway - ScienceDirect

The Lancet Commission on lessons for the future from the COVID-19 pandemic - The Lancet

Effects of guar gum on blood lipid levels: A systematic review and meta-analysis on randomized clinical trials - ScienceDirect

Efficacy of e-health interventions for smoking cessation management in smokers: a systematic review and meta-analysis - eClinicalMedicine